NTN Swiss Biotech – A Look at Support Measures for Dynamic Start-ups

Biotechnet Switzerland

Authors

  • Elsbeth Heinzelmann Journalist science + technology

DOI:

https://doi.org/10.2533/chimia.2016.121

Keywords:

Ntn swiss biotech, Red biotechnology, Start-up

Abstract

The Swiss biotech landscape seems to be on a healthy footing: There are many imaginative start-ups, we have first-class hospitals, highly advanced clinical research and the availability of a great deal of capital. But we have no reason to rest on our laurels as countries like the USA lead the field. We must lay down the tracks today to remain an attractive country and maintain our ranking among the 10 best locations.
CHIMIA Vol. 70 No. 1-2 (2016): The French Connection

Downloads

Published

2016-02-24

How to Cite

[1]
E. Heinzelmann, Chimia 2016, 70, 121, DOI: 10.2533/chimia.2016.121.

Issue

Vol. 70 No. 1-2 (2016): The French Connection

Section

Columns, Conference Reports

Categories

License

Copyright (c) 2016 Swiss Chemical Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.